Company Overview More
Biofrontera Inc., a biopharmaceutical company, develops and provides dermatological products for the treatment of skin diseases in the United States. It primarily develops therapies for non-melanoma skin cancer. It offers Ameluz, an aminolevulinic acid hydrochloride gel for the photodynamic therapy of actinic keratoses; and BF-RhodoLED, an LED lamp emitting red light for use in photodynamic therapy. The company was founded in 1997 and is based in Woburn, Massachusetts.
CEO: Lubbert, Hermann
Market: NASDAQ
Futu Hot List
USHKCN
Trade HeatSearch HeatNews Heat
SymbolLatest Price% Chg

Loading...

Moomoo > Quotes > BFRI Biofrontera > Detailed Quotes

BFRI Biofrontera

7.900+2.680+51.34%
Close 11/26 16:54 ET
7.810-0.09-1.14%
Post Mkt Price 11/26 16:59 ET
High
9.490
Open
7.200
Turnover
795.66M
Low
6.580
Prev.Close
5.220
Volume
103.36M
Market Cap
91.64M
P/E(TTM)
Loss
52Wk High
9.490
Shares
11.60M
P/E
Loss
52Wk Low
2.250
H Mkt Cap
28.44M
Bid-Ask Ratio
71.43%
Historical High
9.490
H Shares
3.60M
Vol. Ratio
4.13
Historical Low
2.250
Dividend TTM
--
Div Yield TTM
--
P/B
-66.95
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
2871.15%
Amplitude
55.75%
Avg Price
7.697
Min Trading Unit
1
Float Market Cap
28.44M
Bid-Ask Ratio
71.43%
Historical High
9.490
Float
3.60M
Vol. Ratio
4.13
Historical Low
2.250
Dividend TTM
--
P/B
-66.95
Dividend LFY
--
Turnover Ratio
2871.15%
Amplitude
55.75%
Avg Price
7.697
Min Trading Unit
1
Price Forecast

Loading...

News